GENE ONLINE|News &
Opinion
Blog

The Rise of Asia as a Destination of Biotech Investment and Opportunity

by Sangeeta Chakraborty
Share To
Dr. Monica He, Senior Director, International Affairs, BIO moderated the session “Asian opportunities and collaboration” that featured distinguished panelists discussing the collaborative opportunities and business models in the pharma and biotech sector of Asia while also touching upon the impact of the pandemic on the future.

GO Prime with only $1.49 now

LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top